Evidence map›Paper›PMID 39996823›Full record

ArticleCurrent issues in molecular biology2025

Vitamin D and LL-37 in Serum and Saliva: Insights into Oral Immunity.

Sotiria Davidopoulou, Kali Makedou, Areti Kourti, Ioanna Gkeka, Panagiotis Karakostas, Maria Pikilidou, Kosmas Tolidis, Sotirios Kalfas

Abstract read
In one paragraph

Article in Current issues in molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Vitamin DFrontiers in oral health · 2026
    Trial
  3. Review
  4. Review
  5. Vitamin DInternational journal of molecular sciences · 2025
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sotiria DavidopoulouDepartment of Operative Dentistry, School of Dentistry, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.ORCID 0000-0002-3436-3606
Kali MakedouLaboratory of Biochemistry, School of Medicine, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.ORCID 0000-0002-2718-7480
Areti KourtiLaboratory of Biochemistry, School of Medicine, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.ORCID 0009-0007-4844-2712
Ioanna GkekaLaboratory of Biochemistry, School of Medicine, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.
Panagiotis KarakostasDepartment of Preventive Dentistry, Periodontology and Implant Biology, School of Dentistry, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.ORCID 0000-0001-7928-0989
Maria PikilidouHypertension Excellence Centre, Second Department of Nephrology, AHEPA Hospital, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.ORCID 0000-0002-9456-3175
Kosmas TolidisDepartment of Operative Dentistry, School of Dentistry, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.ORCID 0000-0002-1452-0539
Sotirios KalfasDepartment of Preventive Dentistry, Periodontology and Implant Biology, School of Dentistry, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.ORCID 0000-0003-3251-2417

Funding

A grand from Procter & Gamble Hellas called ""Annual Endowed Sponsorship in Memory of Th. Koulouridis" in 2021. 2021
6 · The paper itself

Abstract

(1) Background: In recent years, there has been a growing interest in understanding the innate immunity of the mouth, particularly the mechanisms through which vitamin D influences oral health. Researchers have increasingly focused on the association between vitamin D and the antimicrobial peptide LL-37 since the CAMP gene, responsible for encoding the LL-37 peptide, is a direct target of both vitamin D and its receptor (vitamin D receptor, VDR). This study aimed to explore the correlation between the 25-hydroxyvitamin D (25(OH)D) levels and the concentration of the LL-37 peptide in both serum and saliva. The objective was to compare the serum concentrations of 25(OH)D and ll-37 with those in saliva and to access the correlations between the two compounds. (2) Methods: Serum and whole saliva samples were collected from 72 healthy adults (mean age 28.68 ± 8.35). The levels of 25(OH)D and LL-37 were assessed in both the saliva and serum samples using commercially available enzyme-linked immunosorbent assay (ELISA) kits. (3) Results: The 25(OH)D levels in the serum (median 5.92 ng/mL, min-max 2.7-10.4 ng/mL) correlated with the LL-37 serum levels (62 ng/mL, min-max 18-378 ng/mL; Pearson's r 0.328,

Indexed as

25-hydroxyvitamin DLL-37 antimicrobial peptidesalivaserum

Identifiers

PMID39996823
PMCPMC11854761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.